|Other names||Paris-Trousseau thrombocytopenia|
Paris-Trousseau syndrome (PTS) is an inherited disorder characterized by mild hemorrhagic tendency associated with 11q chromosome deletion. It manifests as a granular defect within an individual's platelets. It is characterized by thrombocytes with defects in α-granule components which affects the cell's surface area and, consequently, its ability to spread when necessary.
- "Paris-Trousseau thrombocytopenia | Genetic and Rare Diseases Information Center (GARD) – an NCATS Program". rarediseases.info.nih.gov. Retrieved 15 March 2019.
- "OMIM Entry - # 188025 - THROMBOCYTOPENIA, PARIS-TROUSSEAU TYPE; TCPT". omim.org. Retrieved 15 March 2019.
- Krishnamurti L, Neglia JP, Nagarajan R, et al. (April 2001). "Paris-Trousseau syndrome platelets in a child with Jacobsen's syndrome". Am. J. Hematol. 66 (4): 295–9. doi:10.1002/ajh.1061. PMID 11279643.
- Sultan, Nasreen; Sharma, S. K. (April 2015). "Platelet Count and Mean Platelet Volume-Key Hematological Indices in Determination of Various Clinical Perspectives-A Review" (PDF). International Journal of Science and Research. 4 (4): 3347–3350. ISSN 2319-7064. SUB154040. Retrieved 28 September 2015.
- Raslova H, Komura E, Le Couédic JP, et al. (July 2004). "FLI1 monoallelic expression combined with its hemizygous loss underlies Paris-Trousseau/Jacobsen thrombopenia". J. Clin. Invest. 114 (1): 77–84. doi:10.1172/JCI21197. PMC 437972. PMID 15232614.
|This genetic disorder article is a stub. You can help Wikipedia by expanding it.|